| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Alta Partners LLC | 7.7% | $2,162,467 | 1,787,163 | Alta Partners LLC | 13 Feb 2026 | |||
| ALSTODT LANCE | 16% | $2,201,520 | 1,236,809 | ALSTODT LANCE | 14 Feb 2025 | |||
| Silva Francisco | 15% | $2,130,338 | 1,196,819 | Silva, Francisco | 14 Feb 2025 | |||
| Auctus Fund Management LLC | 9.9% | 0% | $1,271,141 | +$41,420 | 784,655 | +3.4% | Auctus Fund, LLC | 30 Jun 2025 |
| Morrison Todd Hale | 7.7% | $732,950 | +$732,950 | 685,000 | Morrison Todd Hale | 18 Dec 2025 |
As of 31 Dec 2025, 8 institutional investors reported holding 283,020 shares of BioRestorative Therapies, Inc. - Common Stock, $0.0001 par value (BRTX). This represents 1.2% of the company’s total 23,209,909 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 283,020 | $331,651 | +$16,157 | $1.17 | 8 |
| 2025 Q3 | 379,488 | $545,311 | +$177,416 | $1.44 | 14 |
| 2025 Q2 | 247,366 | $412,419 | -$29,039 | $1.67 | 15 |
| 2025 Q1 | 281,898 | $501,776 | +$4,467 | $1.78 | 14 |
| 2024 Q4 | 283,612 | $405,563 | +$6,095 | $1.43 | 15 |
| 2024 Q3 | 272,185 | $471,917 | +$25,939 | $1.74 | 15 |
| 2024 Q2 | 256,145 | $519,973 | -$123,707 | $2.03 | 13 |
| 2024 Q1 | 384,984 | $530,968 | +$79,319 | $1.38 | 13 |
| 2023 Q4 | 312,403 | $540,922 | -$90,093 | $1.74 | 13 |
| 2023 Q3 | 362,913 | $648,725 | +$63,021 | $1.79 | 14 |
| 2023 Q2 | 322,637 | $1,422,829 | +$122,754 | $4.41 | 13 |
| 2023 Q1 | 298,901 | $1,016,792 | -$44,007 | $3.40 | 15 |
| 2022 Q4 | 327,690 | $899,848 | -$84,695 | $2.75 | 15 |
| 2022 Q3 | 358,231 | $1,156,301 | +$89,065 | $3.22 | 13 |
| 2022 Q2 | 330,604 | $974,116 | -$41,559 | $2.95 | 11 |
| 2022 Q1 | 344,602 | $1,801,209 | -$261,514 | $5.22 | 9 |
| 2021 Q4 | 396,349 | $1,720,900 | +$1,231,900 | $4.34 | 8 |